IIVS appoints Frank Gerberick as chief scientific advisor
Aimmune Therapeutics Begins Public Offering of USD 150m of Common Stock
Aimmune Therapeutics Begins Public Offering of USD 150m of Common Stock
Eurofins BPT Munich to Market SenzaGen GARD tests
SenzaGen enters into first global licensing agreement with Eurofins BPT Munich
Japanese paediatric approval for Stallergenes Greer's Actair
Oricula Therapeutics to Commence Human Testing of Hearing Loss Prevention Candidate
Comprehensive Celiac Disease and Gluten Sensitivity Testing Available from True Health